⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMBR News
Amber International Holding Limited American Depositary Shares
Amber Premium Announces First 2026 English-Language Digital Asset Webinar, Building on Record Audience Growth USA - English APAC - English
prnewswire.com
AMBR
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
La Luce Cristallina Launches CMOS-Compatible Oxide Pseudo-Substrate, Enhancing Scalability for Silicon Photonics and Advanced Electronics
prnewswire.com
AMBR
AGM Holdings Signs Strategic Memorandum of Understanding to Enter the New Arena of Real-World Asset (RWA) Tokenization
globenewswire.com
AGMH
AMBR
AGM Group Announces Strategic Memorandum of Understanding with Amber Premium in Building RWA Tokenization Initiatives
globenewswire.com
AGMH
AMBR
Amber Premium FZE Secures In-Principle Approval from VARA for Virtual Asset Service Provider License in Dubai
prnewswire.com
AMBR
Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1
prnewswire.com
AMBR
Amber International Holding Limited Reports Third Quarter 2025 Unaudited Financial Results and Announces Share Repurchase Program
prnewswire.com
AMBR
Amber International Holding Limited Announces $50 Million Share Repurchase Program Following Strong Q3 Earnings USA - English APAC - English
prnewswire.com
AMBR
Amber International Holding Limited to Report Third Quarter 2025 Financial Results and Host Earnings Call on November 26, 2025
prnewswire.com
AMBR